NASDAQ · Financial Statements

HealthEquity, Inc. (HQY) Financial Statements

$103.97 NASDAQ: HQY Market Cap $8.60B

HealthEquity, Inc. most recently reported annual revenue of $1.3B, net profit of $215.0M. Revenue grew at an average annual rate of 12.3% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

HealthEquity, Inc.: Revenue rose from $178.0M in 2017 to $1.3B in 2026, a change of +637.6% over 9 years; net profit was positive in 8 of 10 reported years; operating margin moved from 23.1% to 24.6%, a shift of +1.4 percentage points; the most recent year shows net profit of $215.0M.

Income Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Revenue$178.0M$230.0M$287.0M$532.0M$734.0M$757.0M$862.0M$1.0B$1.2B$1.3B
Operating Expenses$137.0M$175.0M$210.0M$423.0M$654.0M$716.0M$824.0M$871.0M$970.0M$991.0M
Operating Profit$41.0M$54.0M$78.0M$109.0M$80.0M$41.0M$38.0M$128.0M$230.0M$322.0M
Operating Margin23.1%23.7%27.0%20.5%10.9%5.4%4.4%12.8%19.2%24.6%
Other Income$-1.0M$-2.0M$-2.0M$-66.0M$-76.0M$-107.0M$-76.0M$-53.0M$-114.0M$-45.0M
Interest$0$0$0$25.0M$35.0M$37.0M$48.0M$55.0M$61.0M$57.0M
Depreciation$13.0M$16.0M$18.0M$55.0M$116.0M$137.0M$161.0M$153.0M$162.0M$155.0M
Profit Before Tax$40.0M$52.0M$76.0M$43.0M$4.0M$-67.0M$-38.0M$75.0M$116.0M$277.0M
Tax$34.3M$9.3M$2.5M$8.1M$-113.4M$33.6M$31.4M$25.8M$16.7M$22.4M
Net Profit$26.0M$47.0M$74.0M$40.0M$9.0M$-44.0M$-26.0M$56.0M$97.0M$215.0M
EPS$0.44$0.77$1.17$0.58$0.12$-0.53$-0.31$0.64$1.09$2.46
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$249.0M$262.0M$288.0M$300.0M$300.0M$312.0M$331.0M$326.0M$322.0M$335.0M$355.0M$351.0M
Operating Expenses$216.0M$221.0M$244.0M$239.0M$246.0M$240.0M$246.0M$235.0M$242.0M$267.0M$252.0M$252.0M
Operating Profit$34.0M$41.0M$44.0M$61.0M$54.0M$72.0M$84.0M$91.0M$80.0M$67.0M$103.0M$99.0M
Operating Margin13.5%15.7%15.2%20.2%18.0%22.9%25.5%27.9%24.8%20.1%29.0%28.1%
Interest$14.0M$14.0M$12.0M$15.0M$18.0M$15.0M$15.0M$15.0M$14.0M$13.0M$13.0M$13.0M
Profit Before Tax$21.0M$30.0M$33.0M$47.0M$6.0M$30.0M$71.0M$78.0M$68.0M$61.0M$92.0M$88.0M
Tax$30.4M$11.3M$13.3M$23.2M$8.3M$12.0M$24.0M$23.3M$23.5M$18.3M$24.9M$25.3M
Net Profit$15.0M$26.0M$29.0M$36.0M$6.0M$26.0M$54.0M$60.0M$52.0M$50.0M$69.0M$66.0M
EPS$0.17$0.30$0.33$0.40$0.06$0.30$0.61$0.68$0.59$0.58$0.82$0.78

Over the 10 years reported for HealthEquity, Inc., cash stood at $319.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 3.26 times.

Balance Sheet — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Total Assets$279.0M$369.0M$510.0M$2.6B$2.7B$3.1B$3.1B$3.2B$3.4B$3.4B
Current Assets$201.0M$265.0M$395.0M$297.0M$460.0M$351.0M$383.0M$557.0M$478.0M$512.0M
Cash$140.0M$199.0M$361.0M$192.0M$329.0M$225.0M$254.0M$404.0M$296.0M$319.0M
Inventory$1.0M$0$0$0$0$0$0$0$0$0
Receivables$17.0M$22.0M$26.0M$71.0M$73.0M$87.0M$97.0M$105.0M$118.0M$124.0M
Fixed Assets$5.0M$8.0M$8.0M$117.0M$119.0M$87.0M$69.0M$54.0M$46.0M$39.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$41.0M$42.0M$0$0$0$0$0$0$0$3.0M
Other Assets$5.0M$5.0M$5.0M$1.3B$1.3B$1.6B$1.6B$1.6B$1.6B$1.6B
Total Liabilities$17.0M$23.0M$33.0M$1.5B$1.3B$1.3B$1.2B$1.1B$1.3B$1.3B
Current Liabilities$16.0M$20.0M$29.0M$152.0M$205.0M$153.0M$131.0M$117.0M$156.0M$157.0M
Borrowings$0$0$0$1.3B$1.1B$1.0B$994.0M$933.0M$1.1B$1.0B
Other Liabilities$17.0M$23.0M$33.0M$234.0M$257.0M$246.0M$199.0M$196.0M$225.0M$323.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$262.0M$346.0M$477.0M$1.0B$1.4B$1.9B$1.9B$2.0B$2.1B$2.1B

For HealthEquity, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $455.0M; free cash flow was positive in 10 of 10 years; financing activities used $298.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Operating Cash Flow$46.0M$82.0M$113.0M$106.0M$182.0M$141.0M$151.0M$243.0M$340.0M$457.0M
Investing Cash Flow$-35.0M$-70.0M$11.0M$-1.8B$-194.0M$-776.0M$-238.0M$-92.0M$-508.0M$-49.0M
Financing Cash Flow$17.0M$0$0$-244.0M$-4.0M$-6.0M$-1.0M$1.0M$-123.0M$-298.0M
Net Cash Flow$56.0M$60.0M$162.0M$-170.0M$137.0M$-103.0M$29.0M$150.0M$-108.0M$23.0M
Free Cash Flow$33.0M$48.0M$98.0M$64.0M$85.0M$4.0M$32.0M$197.0M$338.0M$455.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.47
EV / EBITDA17.28
FCF Yield6.38%
Quick Ratio2.99
Interest Coverage6.64
Return 1Y3.73%
Return 3Y22.02%
Return 5Y40.47%

HealthEquity, Inc. (HQY) financials — frequently asked questions

What is HealthEquity, Inc.'s annual revenue?

HealthEquity, Inc. (HQY) reported annual revenue of $1.3B in its most recent fiscal year.

What is HealthEquity, Inc.'s net profit?

HealthEquity, Inc. (HQY) reported net profit of $215.0M in its most recent fiscal year.

What is HQY EV/EBITDA?

HealthEquity, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 17.28.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
HQY Overview HQY Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.